4-{[5-(cyclohexylmethoxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide

This compound is a synthetic small molecule belonging to the benzenesulfonamide class. It features a triazolopyrimidine core substituted with a cyclohexylmethoxy group and an aminobenzenesulfonamide moiety. The compound is experimental and not approved for clinical use in any country. Its primary known mechanism of action is as an inhibitor of cyclin-dependent kinase 2 (CDK2), which plays a key role in cell cycle regulation. There are no reported clinical trials or approved indications for this molecule as of now. It has been studied primarily in research settings as a potential tool compound for modulating CDK activity and possibly other kinases involved in cell proliferation pathways.[1][6][9]

Other names

4-{[5-(cyclohexylmethoxy)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide4-{[5-(cyclohexylméthoxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzènesulfonamide (French)4-{[5-(cyclohexylmethoxy)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yloxy]}benzenesulfonamideBenzenesulfonamide, 4-[[(Cyclohexylmethoxy)]]